Pd14-05 Neoadjuvant Enzalutamide and Androgen Deprivation in High-Risk Prostate Cancer: Initial Imaging and Surgical Findings From a Phase Ii Clinical Trial

Journal of Urology - Netherlands
doi 10.1016/j.juro.2018.02.791
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Results of a Phase II Trial of Neoadjuvant Abiraterone + Prednisone+ Enzalutamide + Leuprolide (APEL) Versus Enzalutamide + Leuprolide (EL) for Patients With High-Risk Localized Prostate Cancer (PC) Undergoing Radical Prostatectomy (RP).

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2018English

Benefit of Whole Pelvic Radiotherapy Combined With Neoadjuvant Androgen Deprivation for the High-Risk Prostate Cancer

Journal of Biomedicine and Biotechnology
2009English

Androgen Deprivation Therapy for Prostate Cancer and Risk of Dementia

BJU International
Urology
2019English

Risk of the "Androgen Deprivation Syndrome" in Men Receiving Androgen Deprivation for Prostate Cancer

Archives of Internal Medicine
2006English

Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men With Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized Trial

Clinical Cancer Research
Cancer ResearchOncology
2016English

Sunitinib Plus Androgen Deprivation and Radiation Therapy for Patients With Localized High-Risk Prostate Cancer: Results From a Multi-Institutional Phase 1 Study

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2013English

Is Neoadjuvant Androgen Deprivation Therapy Necessary for Patients With Intermediate-Risk Prostate Cancer Treated With Proton Therapy?

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

High-Dose Radiation Employing External Beam Radiotherapy and High-Dose Rate Brachytherapy With and Without Neoadjuvant Androgen Deprivation for Prostate Cancer Patients With Intermediate- And High-Risk Features

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2006English

Preoperative Androgen Deprivation Therapy for Localized Prostate Cancer: Delayed Biochemical Recurrence in High-Risk Disease

Clinical Genitourinary Cancer
OncologyUrology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy